Check out the companies which will be in focus during trade today based on recent and latest news developments.
Sun Pharma: The the Board of Directors of the Company at its meeting held on June 23, 2016 approved the buyback of its fully paid up equity shares. The buyback is being undertaken by the Company to return surplus funds to the equity shareholders and thereby, enhancing the overall returns to shareholders.
ONGC: ONGC Petro additions Ltd is in talks with local and overseas petrochemical companies to sell as much as 25% in the company, as per media reports.
Tata Motors: Tata Motors Ltd-owned Jaguar Land Rover (JLR) has begun recalling more than 11,000 vehicles in China due to faulty crankshaft sensors, as per reports.
Shilpa Medicare: Shilpa Medicare informed BSE that a meeting of the Board of Directors of the Company will be held on June 27, 2016, inter alia, to consider a proposal of merger of Navya Boilogicals Private Limited with the Company.
Goa Carbon Ltd: Goa Carbon informed BSE that the operations at the Company’s Bilaspur Plant located at 34-40, Sect B, Sirgitti Industrial Area, Bilaspur (Chattisgarh) has been temporarily shut down for maintenance work from June 22, 2016. There would not be any financial impact due to the temporary shutdown of the Company’s Bilaspur Unit as there sufficient inventory to service the orders in hand.
Allahabad Bank: The bank is planning to grow its retail lending book by one-fifth this fiscal, expecting a consumption-led economic growth this fiscal with higher government's spending on salaries.
Shree Renuka Sugars: Shree Renuka Sugars has signed a share sale agreement with Mauritius based fund to sell 5% remaining stake in NCDEX.
Essar Shipping Ltd: The company has announced that the Board of Directors of the Company at its meeting held on June 23, 2016 has passed the enabling resolution to sell older vessel(s) and/ or buy the younger vessel(s) for the Company.
JSW Energy: The company have reopened talks with the Jaypee Group on acquiring three power assets, according to reports.
State Bank of India: The bank has announced that a meeting of the Executive Committee of the Central Board of the Bank is scheduled to be held on June 29, 2016 at Mumbai to examine the status and decide on long term fund raising in single/multiple tranches up to US$ 1,500 million (US$ one thousand five hundred million) through a public offer and/or private placement of senior unsecured notes in US Dollar or any other convertible currency during the financial year 2016-17.
Glenmark Pharmaceutical: Government will consider 15 foreign investment proposals, including those of Glenmark Pharmaceutical, Sistema Shyam TeleServices, Quintillion Business Media and Morgan Stanley India Primary Dealer, for approval on July 5.
Advanta Ltd: The company announced that High Court of Gujarat at Ahmedabad has approved the Scheme of Amalgamation of Advanta and UPL Limited and their respective Shareholders and Creditors (“Scheme”) on June 23, 2016.
Omax Autos Ltd: The company has announced that Railway Division of the Company has successfully secured order for supply of Railway parts from Indian Railways for order value estimated between Rs. 90-100 Crores. Formal Purchase Order would be received by the Company in due course of time.
HDFC: HDFC has invoked 35,000 shares of United Spirits (USL) pledged to it by Kingfisher Finvest India, as per media reports.
Aditya Birla Fashion and Retail: A division of Aditya Birla Fashion and Retail Limited (formerly known as Pantaloons Fashion & Retail Limited) (“Pantaloons”) added yet another international brand Izabel London to its rich portfolio of exclusive brands.
Indiabulls Housing Finance Ltd: The Company proposes to issue 500 Secured Non-Convertible Redeemable Debentures with a face value of Rs. 10 lakh each aggregating to Rs. 50 Crores (Plus Greenshoe Option), on Private Placement basis, pursuant to special resolution passed by the shareholders of the Company at the 10th Annual General Meeting held on September 07, 2015, on the terms and conditions.
Biocon: Biocon said the Drug Controller General of India (DCGI) has given nod to it and partner Quark Pharmaceuticals to proceed with clinical trials on human subjects for a new drug candidate, ‘QPI-1007’ aimed for ocular neuroprotection.